Literature DB >> 6367682

Should women taking antituberculosis drugs breast-feed?

D E Snider, K E Powell.   

Abstract

Most of the commonly used antituberculosis drugs are excreted in the breast milk of nursing mothers. However, only a small fraction of the adult dose appears in breast milk, and we estimate that breast-fed infants would receive no more than 20% of the usual therapeutic dose for infants for any of these drugs. Based on these considerations, we believe the risk of toxic reactions to drugs in infants of nursing mothers receiving antituberculosis drugs is very low. Nevertheless, the decision to breast-feed while taking antituberculosis drugs must be an individual one that takes into account the known facts, professional opinion, and the patient's values and preferences.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367682

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

Review 1.  Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues.

Authors:  Chrysanthi L Skevaki; Dimitrios A Kafetzis
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 2.  Treatment of tuberculosis in newborn infants and their mothers.

Authors:  M C Steinhoff; J Lionel
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

3.  Drugs in lactation.

Authors:  D A MacKintosh
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

4.  Tuberculosis Meningitis.

Authors:  Thomas Byrd; Phil Zinser
Journal:  Curr Treat Options Neurol       Date:  2001-09       Impact factor: 3.598

Review 5.  Effect of maternal antibiotics on breast feeding infants.

Authors:  J L Mathew
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

6.  Transfer of isoniazid from circulation to breast milk in lactating women on chronic therapy for tuberculosis.

Authors:  Neera Singh; Anil Golani; Zarine Patel; Anurupa Maitra
Journal:  Br J Clin Pharmacol       Date:  2007-12-17       Impact factor: 4.335

Review 7.  Drug treatment of tuberculosis--1992.

Authors:  P T Davidson; H Q Le
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

Review 8.  Clinical pharmacokinetics of the antituberculosis drugs.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

9.  The use of anti-tuberculosis therapy for latent TB infection.

Authors:  Justin T Denholm; Emma S McBryde
Journal:  Infect Drug Resist       Date:  2010-07-21       Impact factor: 4.003

10.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.